Google Ven­tures’ Kr­ish­na Yesh­want is hunt­ing for the next big new idea in biotech

Bill Maris brought in Kr­ish­na Yesh­want as a Google Ven­tures part­ner back in the ear­ly days of 2009. The Har­vard MD/MBA with a com­put­er sci­ences back­ground at Stan­ford and a track record of his own start­ing and sell­ing soft­ware com­pa­nies had that blend of ed­u­ca­tion, youth­ful ex­pe­ri­ence and cross-pol­li­nat­ing in­tel­lect Google want­ed to bring to its in­vest­ment group.

Maris is leav­ing now, but Yesh­want is stay­ing put, run­ning a cross-coun­try life sci­ences team that con­tin­ues to hunt out pre-fledg­ling in­vest­ments in biotech. Where most VCs in the biotech world op­er­ate with a very clear ex­it strat­e­gy — whether they’re go­ing for the long throw of a dis­tant IPO or a quick val­ue mak­er 12 months from the first mon­ey in — Yesh­want and his crew mem­bers are hap­py to play the long game, with­out keep­ing an eye on the clock.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER